Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus

Sahena Haque, Hoda Mirjafari, Ian N. Bruce

    Research output: Contribution to journalArticlepeer-review


    There is an urgent need for clinical trials to examine both the lipid-lowering and inflammatory hypotheses of atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Novel targeted therapies in development may also have a major impact on future coronary heart disease risk in these conditions. © 2008 Wolters Kluwer Health | Lippincott Williams & Wilkins.
    Original languageEnglish
    Pages (from-to)338-343
    Number of pages5
    JournalCurrent opinion in lipidology
    Issue number4
    Publication statusPublished - Aug 2008


    • Atherosclerosis
    • Coronary heart disease
    • Interferon
    • Rheumatoid arthritis
    • Systemic lupus erythematosus
    • Tumour necrosis factor alpha


    Dive into the research topics of 'Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus'. Together they form a unique fingerprint.

    Cite this